Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Journal of Hematology & Oncology
|
December 3, 2020
Novel therapeutics in myeloproliferative neoplasms
Sangeetha Venugopal, John Mascarenhas
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy
Sangeetha Venugopal, Justin Watts
Blood Advances
|
May 17, 2023
Olutasidenib: from bench to bedside
Sangeetha Venugopal, Justin Watts
Clinical Lymphoma, Myeloma & Leukemia
|
December 25, 2018
Chronic Neutrophilic Leukemia: Current and Future Perspectives
Sangeetha Venugopal, John Mascarenhas
Hematology/Oncology Clinics of North America
|
March 1, 2021
Current Clinical Investigations in Myelofibrosis
Sangeetha Venugopal, John Mascarenhas
Blood Advances
|
May 27, 2022
The odyssey of pacritinib in myelofibrosis
Sangeetha Venugopal, John Mascarenhas
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
October 15, 2023
Current State and Future Prospects of Diagnosis and Management of TP53-Mutated Myeloid Neoplasms
Sangeetha Venugopal, Sanam Loghavi
Seminars in Hematology
|
October 19, 2024
Therapy-related myelodysplastic syndromes and acute myeloid leukemia
Sangeetha Venugopal, Amy E DeZern
Leukemia & Lymphoma
|
April 8, 2023
Raising the bar for lower-risk myelodysplastic syndromes
Sangeetha Venugopal, Mikkael A Sekeres
JAMA Oncology
|
August 8, 2024
Contemporary Management of Acute Myeloid Leukemia: A Review
Sangeetha Venugopal, Mikkael A Sekeres
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Journal of Hematology & Oncology
|
December 3, 2020
Novel therapeutics in myeloproliferative neoplasms
Sangeetha Venugopal, John Mascarenhas
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy
Sangeetha Venugopal, Justin Watts
Blood Advances
|
May 17, 2023
Olutasidenib: from bench to bedside
Sangeetha Venugopal, Justin Watts
Clinical Lymphoma, Myeloma & Leukemia
|
December 25, 2018
Chronic Neutrophilic Leukemia: Current and Future Perspectives
Sangeetha Venugopal, John Mascarenhas
Hematology/Oncology Clinics of North America
|
March 1, 2021
Current Clinical Investigations in Myelofibrosis
Sangeetha Venugopal, John Mascarenhas
Blood Advances
|
May 27, 2022
The odyssey of pacritinib in myelofibrosis
Sangeetha Venugopal, John Mascarenhas
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
October 15, 2023
Current State and Future Prospects of Diagnosis and Management of TP53-Mutated Myeloid Neoplasms
Sangeetha Venugopal, Sanam Loghavi
Seminars in Hematology
|
October 19, 2024
Therapy-related myelodysplastic syndromes and acute myeloid leukemia
Sangeetha Venugopal, Amy E DeZern
Leukemia & Lymphoma
|
April 8, 2023
Raising the bar for lower-risk myelodysplastic syndromes
Sangeetha Venugopal, Mikkael A Sekeres
JAMA Oncology
|
August 8, 2024
Contemporary Management of Acute Myeloid Leukemia: A Review
Sangeetha Venugopal, Mikkael A Sekeres
Page
of 4